Structure of the cyclin-dependent kinase inhibitor p19(Ink4d)

Nature

Volumn 389, Issue 6654, 1997, Pages 999-1003

  Luh, Frederich Y ^a   Archer, Sharon J ^b   Domaille, Peter J ^b   Smith, Brian O ^a   Owen, Darerca ^a   Brotherton, Deborah H ^a   Raine, Andrew R C ^a   Xu, Xu ^c   Brizuela, Leonardo ^c   Brenner, Stephen L ^b   Laue, Ernest D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b DUPONT COMPANY   (United States)

^c GPC Biotech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; ESCHERICHIA COLI; GENE MUTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; ANKYRINS; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P19; CYCLIN-DEPENDENT KINASES; CYCLINS; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0030666003     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/40202     Document Type: Article

References (30)

1. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677 (1996).
2. INK4. Mol. Cell. Biol. 15, 2682- 2688 (1995).
3. INK4d, a p16 related inhibitor specific to CDK6 and CDK4. Mol. Biol. Cell. 7, 57-70 (1996).
4. Hirai, H., Roussel, M. F., Kato, H.-Y., Ashmun, R. A. & Sherr, C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681 (1995).
5. INK4a proteins encoded by tumor-derived alleles. J. Biol. Chem. 271, 28734-28737 (1996).
6. Serrano, M., Hannon, G. J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/Cdk4. Nature 366, 704-707 (1993).
7. Bork, P. Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally. Prot. Struct. Funct. Genet. 17, 363-374 (1993).
8. INK4B is a potential effector of TGF-β-induced cell-cycle arrest. Nature 371, 257-261 (1994).
9. Foulkes, W. D., Flanders, T. Y., Pollock, P. M. & Hayward, N. K. The CDKN2A (p16) gene and human cancer Mol. Med. 3, 5-20 (1997).
10. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37 (1996).
11. CDKN2/MTS1 in human cancers. Nature Med. 1, 686-692 (1995).
12. Yasukawa, T. et al. Increase of solubility of foreign proteins in Escherichia coli by co-production of the bacterial thioredoxin. J. Biol. Chem. 270, 25328-25331 (1995).
13. Wick, S. T., Dubay, M. M., Imanil, I. & Brizuela, L. Biochemical and mutagenic analysis of the melanoma tumor-suppressor gene-product p16. Oncogene 11, 2013-2019 (1995).
14. INK4A-insensitive CDK4 mutant targeted by cytolytic T-lymphocytes in a human melanoma. Science 269, 1281-1284 (1995).
15. INK4d. FEBS Lett. 401,127-132 (1997).
16. Gorina, S. & Pavletich, N. P. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001-1005 (1996).
17. INK4A: Structural characterization of wild-type and mutant proteins by NMR and circular dichroism. Biochemistry 35, 9475-9487 (1996).
18. INK4a tumor suppressor protein. Cancer Res. 55, 2503-2506 (1995).
19. INK4 function. Nature Genet. 10, 114-116 (1995).
20. Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 575, 506-510 (1995).
21. CDKN2 associated with familial melanoma. Mol. Cell. Biol. 16, 3844-3852 (1996).
22. CDKN2/INK4A Curr. Biol, 6, 84-91 (1996).
23. Smith, B. O. et al. An approach to global fold determination using limited NMR data from larger proteins selectively protonated at specific residue types. J. Biomol. NMR 8, 360-368 (1996).
24. Clowes, R. T., Crawford, A., Raine, A. R. C., Smith, B. O. & Laue, E. D. Structural studies of proteins using NMR spectroscopy. Curr. Opin. Biotechnol. 6, 81-88 (1995).
25. Brünger, A. T. X-PLOR, Version 3.1: A System for X-ray Crystallography and NMR (Yale Univ. Press, New Haven and London, 1992).
26. Clore, G. M. & Gronenborn, A. M. Structures of larger proteins in solution-3-dimensional and 4-dimensional heteronuclear NMR spectroscopy. Science 252, 1390-1399 (1991).
27. 15N-enriched proteins. J. Am. Chem. Soc. 115, 7772-7777 (1993).
28. Nilges, M., Marcias, M. J., O'Donoghue, S. I. & Oschkinat, H. Automated NOESY interpretation with ambiguous distance restraints: the refined NMR solution structure of the pleckstrin homology domain from β-spectrin. J. Mol. Biol. 269, 408-422 (1997).
29. Kraulis, P. J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).
30. Gilson, M. K., Sharp, K. A. & Honig, B. Calculation of the total electrostatic energy of a macromolecular system - solvation energies, binding energies and conformational analysis. J. Comput. Chem. 9, 327-335 (1988).